2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.

@article{Byrne20102yearCA,
  title={2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.},
  author={Robert A. Byrne and Adnan Kastrati and Klaus Tiroch and Stefanie R Schulz and Juergen Pache and Susanne Pinieck and Steffen Massberg and Melchior Seyfarth and Karl-Ludwig Laugwitz and Katrin Anette Birkmeier and Albert Schoemig and Julinda Mehilli},
  journal={Journal of the American College of Cardiology},
  year={2010},
  volume={55 23},
  pages={
          2536-43
        }
}
OBJECTIVES In the ISAR-TEST-2 (Intracoronary Stenting and Angiographic Results: Test Efficacy of Three Limus-Eluting Stents) randomized trial, a new-generation sirolimus- and probucol-eluting stent (Dual-DES) demonstrated a 12-month efficacy that was comparable to sirolimus-eluting stents (SES) (Cypher, Cordis Corp., Warren, New Jersey) and superior to zotarolimus-eluting stents (ZES) (Endeavor, Medtronic CardioVascular, Santa Rosa, California). The aim of the current study was to investigate… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 52 CITATIONS

FILTER CITATIONS BY YEAR

2010
2017

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 3 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Similar Papers

Loading similar papers…